Adjuvant 131I treatment increases specificity of the further serum thyroglobulin follow-up, as in patients operated because of differentiated thyroid carcinoma but not treated by 131I the source of Tg might be both healthy thyroid cells and cancer cells. Here, TG is linked to cancer.